ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inactivated Hepatitis A Vaccine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-36N16760
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Inactivated Hepatitis A Vaccine Market Research Report 2024
BUY CHAPTERS

Global Inactivated Hepatitis A Vaccine Market Research Report 2025

Code: QYRE-Auto-36N16760
Report
September 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hualan Vaccine
Sinovac
GSK
Merck
Sanofi
KM Biologics
Imbcams
AIM Vaccine
AIM Action

Inactivated Hepatitis A Vaccine Market

The global market for Inactivated Hepatitis A Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Inactivated Hepatitis A Vaccine is a type of vaccine designed to protect against the Hepatitis A virus. Hepatitis A is a viral infection that primarily affects the liver and is usually spread through contaminated food or water. The inactivated Hepatitis A vaccine is a preventive measure that helps the immune system recognize and fight the virus.
North American market for Inactivated Hepatitis A Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inactivated Hepatitis A Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Inactivated Hepatitis A Vaccine include Hualan Vaccine, SINOVAC, GSK, Merck, Sanofi, KM Biologics, IMBCAMS, AIM Vaccine, AIM Action, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inactivated Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Hepatitis A Vaccine.
The Inactivated Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Hepatitis A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inactivated Hepatitis A Vaccine Market Report

Report Metric Details
Report Name Inactivated Hepatitis A Vaccine Market
Segment by Type
  • 1.0ml
  • 0.5ml
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hualan Vaccine, SINOVAC, GSK, Merck, Sanofi, KM Biologics, IMBCAMS, AIM Vaccine, AIM Action
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inactivated Hepatitis A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inactivated Hepatitis A Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Inactivated Hepatitis A Vaccine Market report?

Ans: The main players in the Inactivated Hepatitis A Vaccine Market are Hualan Vaccine, SINOVAC, GSK, Merck, Sanofi, KM Biologics, IMBCAMS, AIM Vaccine, AIM Action

What are the Application segmentation covered in the Inactivated Hepatitis A Vaccine Market report?

Ans: The Applications covered in the Inactivated Hepatitis A Vaccine Market report are Hospital, Clinic

What are the Type segmentation covered in the Inactivated Hepatitis A Vaccine Market report?

Ans: The Types covered in the Inactivated Hepatitis A Vaccine Market report are 1.0ml, 0.5ml

1 Inactivated Hepatitis A Vaccine Market Overview
1.1 Product Definition
1.2 Inactivated Hepatitis A Vaccine by Type
1.2.1 Global Inactivated Hepatitis A Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 1.0ml
1.2.3 0.5ml
1.3 Inactivated Hepatitis A Vaccine by Application
1.3.1 Global Inactivated Hepatitis A Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Inactivated Hepatitis A Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Hepatitis A Vaccine Revenue 2020-2031
1.4.2 Global Inactivated Hepatitis A Vaccine Sales 2020-2031
1.4.3 Global Inactivated Hepatitis A Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inactivated Hepatitis A Vaccine Market Competition by Manufacturers
2.1 Global Inactivated Hepatitis A Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Hepatitis A Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inactivated Hepatitis A Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inactivated Hepatitis A Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Date of Enter into This Industry
2.8 Global Inactivated Hepatitis A Vaccine Market Competitive Situation and Trends
2.8.1 Global Inactivated Hepatitis A Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inactivated Hepatitis A Vaccine Players Market Share by Revenue
2.8.3 Global Inactivated Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inactivated Hepatitis A Vaccine Market Scenario by Region
3.1 Global Inactivated Hepatitis A Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inactivated Hepatitis A Vaccine Sales by Region: 2020-2031
3.2.1 Global Inactivated Hepatitis A Vaccine Sales by Region: 2020-2025
3.2.2 Global Inactivated Hepatitis A Vaccine Sales by Region: 2026-2031
3.3 Global Inactivated Hepatitis A Vaccine Revenue by Region: 2020-2031
3.3.1 Global Inactivated Hepatitis A Vaccine Revenue by Region: 2020-2025
3.3.2 Global Inactivated Hepatitis A Vaccine Revenue by Region: 2026-2031
3.4 North America Inactivated Hepatitis A Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Hepatitis A Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inactivated Hepatitis A Vaccine Sales by Country (2020-2031)
3.4.3 North America Inactivated Hepatitis A Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inactivated Hepatitis A Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Hepatitis A Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inactivated Hepatitis A Vaccine Sales by Country (2020-2031)
3.5.3 Europe Inactivated Hepatitis A Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Hepatitis A Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Inactivated Hepatitis A Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inactivated Hepatitis A Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Inactivated Hepatitis A Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inactivated Hepatitis A Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Hepatitis A Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inactivated Hepatitis A Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Inactivated Hepatitis A Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Hepatitis A Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Hepatitis A Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inactivated Hepatitis A Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inactivated Hepatitis A Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inactivated Hepatitis A Vaccine Sales by Type (2020-2031)
4.1.1 Global Inactivated Hepatitis A Vaccine Sales by Type (2020-2025)
4.1.2 Global Inactivated Hepatitis A Vaccine Sales by Type (2026-2031)
4.1.3 Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Inactivated Hepatitis A Vaccine Revenue by Type (2020-2031)
4.2.1 Global Inactivated Hepatitis A Vaccine Revenue by Type (2020-2025)
4.2.2 Global Inactivated Hepatitis A Vaccine Revenue by Type (2026-2031)
4.2.3 Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Inactivated Hepatitis A Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inactivated Hepatitis A Vaccine Sales by Application (2020-2031)
5.1.1 Global Inactivated Hepatitis A Vaccine Sales by Application (2020-2025)
5.1.2 Global Inactivated Hepatitis A Vaccine Sales by Application (2026-2031)
5.1.3 Global Inactivated Hepatitis A Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Inactivated Hepatitis A Vaccine Revenue by Application (2020-2031)
5.2.1 Global Inactivated Hepatitis A Vaccine Revenue by Application (2020-2025)
5.2.2 Global Inactivated Hepatitis A Vaccine Revenue by Application (2026-2031)
5.2.3 Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Inactivated Hepatitis A Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hualan Vaccine
6.1.1 Hualan Vaccine Company Information
6.1.2 Hualan Vaccine Description and Business Overview
6.1.3 Hualan Vaccine Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hualan Vaccine Inactivated Hepatitis A Vaccine Product Portfolio
6.1.5 Hualan Vaccine Recent Developments/Updates
6.2 SINOVAC
6.2.1 SINOVAC Company Information
6.2.2 SINOVAC Description and Business Overview
6.2.3 SINOVAC Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 SINOVAC Inactivated Hepatitis A Vaccine Product Portfolio
6.2.5 SINOVAC Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Inactivated Hepatitis A Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Inactivated Hepatitis A Vaccine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Inactivated Hepatitis A Vaccine Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 KM Biologics
6.6.1 KM Biologics Company Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 KM Biologics Inactivated Hepatitis A Vaccine Product Portfolio
6.6.5 KM Biologics Recent Developments/Updates
6.7 IMBCAMS
6.7.1 IMBCAMS Company Information
6.7.2 IMBCAMS Description and Business Overview
6.7.3 IMBCAMS Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 IMBCAMS Inactivated Hepatitis A Vaccine Product Portfolio
6.7.5 IMBCAMS Recent Developments/Updates
6.8 AIM Vaccine
6.8.1 AIM Vaccine Company Information
6.8.2 AIM Vaccine Description and Business Overview
6.8.3 AIM Vaccine Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AIM Vaccine Inactivated Hepatitis A Vaccine Product Portfolio
6.8.5 AIM Vaccine Recent Developments/Updates
6.9 AIM Action
6.9.1 AIM Action Company Information
6.9.2 AIM Action Description and Business Overview
6.9.3 AIM Action Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AIM Action Inactivated Hepatitis A Vaccine Product Portfolio
6.9.5 AIM Action Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Hepatitis A Vaccine Industry Chain Analysis
7.2 Inactivated Hepatitis A Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Hepatitis A Vaccine Production Mode & Process Analysis
7.4 Inactivated Hepatitis A Vaccine Sales and Marketing
7.4.1 Inactivated Hepatitis A Vaccine Sales Channels
7.4.2 Inactivated Hepatitis A Vaccine Distributors
7.5 Inactivated Hepatitis A Vaccine Customer Analysis
8 Inactivated Hepatitis A Vaccine Market Dynamics
8.1 Inactivated Hepatitis A Vaccine Industry Trends
8.2 Inactivated Hepatitis A Vaccine Market Drivers
8.3 Inactivated Hepatitis A Vaccine Market Challenges
8.4 Inactivated Hepatitis A Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Hualan Vaccine
Sinovac
GSK
Merck
Sanofi
KM Biologics
Imbcams
AIM Vaccine
AIM Action
List of Tables
 Table 1. Global Inactivated Hepatitis A Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Inactivated Hepatitis A Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Inactivated Hepatitis A Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Inactivated Hepatitis A Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Inactivated Hepatitis A Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Inactivated Hepatitis A Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Inactivated Hepatitis A Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Inactivated Hepatitis A Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inactivated Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Hepatitis A Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inactivated Hepatitis A Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Inactivated Hepatitis A Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Inactivated Hepatitis A Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Inactivated Hepatitis A Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Inactivated Hepatitis A Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Inactivated Hepatitis A Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Inactivated Hepatitis A Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Inactivated Hepatitis A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Inactivated Hepatitis A Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Inactivated Hepatitis A Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Inactivated Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Inactivated Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Inactivated Hepatitis A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Inactivated Hepatitis A Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Inactivated Hepatitis A Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Inactivated Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Inactivated Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Inactivated Hepatitis A Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Inactivated Hepatitis A Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Inactivated Hepatitis A Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Inactivated Hepatitis A Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Inactivated Hepatitis A Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Inactivated Hepatitis A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Inactivated Hepatitis A Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Inactivated Hepatitis A Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Inactivated Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inactivated Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Inactivated Hepatitis A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Inactivated Hepatitis A Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Inactivated Hepatitis A Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Inactivated Hepatitis A Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Inactivated Hepatitis A Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Inactivated Hepatitis A Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Inactivated Hepatitis A Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Inactivated Hepatitis A Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Inactivated Hepatitis A Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Inactivated Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Inactivated Hepatitis A Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Hualan Vaccine Company Information
 Table 71. Hualan Vaccine Description and Business Overview
 Table 72. Hualan Vaccine Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hualan Vaccine Inactivated Hepatitis A Vaccine Product
 Table 74. Hualan Vaccine Recent Developments/Updates
 Table 75. SINOVAC Company Information
 Table 76. SINOVAC Description and Business Overview
 Table 77. SINOVAC Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. SINOVAC Inactivated Hepatitis A Vaccine Product
 Table 79. SINOVAC Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Inactivated Hepatitis A Vaccine Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck Inactivated Hepatitis A Vaccine Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi Inactivated Hepatitis A Vaccine Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. KM Biologics Company Information
 Table 96. KM Biologics Description and Business Overview
 Table 97. KM Biologics Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. KM Biologics Inactivated Hepatitis A Vaccine Product
 Table 99. KM Biologics Recent Developments/Updates
 Table 100. IMBCAMS Company Information
 Table 101. IMBCAMS Description and Business Overview
 Table 102. IMBCAMS Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. IMBCAMS Inactivated Hepatitis A Vaccine Product
 Table 104. IMBCAMS Recent Developments/Updates
 Table 105. AIM Vaccine Company Information
 Table 106. AIM Vaccine Description and Business Overview
 Table 107. AIM Vaccine Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. AIM Vaccine Inactivated Hepatitis A Vaccine Product
 Table 109. AIM Vaccine Recent Developments/Updates
 Table 110. AIM Action Company Information
 Table 111. AIM Action Description and Business Overview
 Table 112. AIM Action Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. AIM Action Inactivated Hepatitis A Vaccine Product
 Table 114. AIM Action Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Inactivated Hepatitis A Vaccine Distributors List
 Table 118. Inactivated Hepatitis A Vaccine Customers List
 Table 119. Inactivated Hepatitis A Vaccine Market Trends
 Table 120. Inactivated Hepatitis A Vaccine Market Drivers
 Table 121. Inactivated Hepatitis A Vaccine Market Challenges
 Table 122. Inactivated Hepatitis A Vaccine Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inactivated Hepatitis A Vaccine
 Figure 2. Global Inactivated Hepatitis A Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inactivated Hepatitis A Vaccine Market Share by Type: 2024 & 2031
 Figure 4. 1.0ml Product Picture
 Figure 5. 0.5ml Product Picture
 Figure 6. Global Inactivated Hepatitis A Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Inactivated Hepatitis A Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Inactivated Hepatitis A Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Inactivated Hepatitis A Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Inactivated Hepatitis A Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Inactivated Hepatitis A Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Inactivated Hepatitis A Vaccine Report Years Considered
 Figure 15. Inactivated Hepatitis A Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Inactivated Hepatitis A Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Inactivated Hepatitis A Vaccine Players: Market Share by Revenue in Inactivated Hepatitis A Vaccine in 2024
 Figure 18. Inactivated Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Inactivated Hepatitis A Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Inactivated Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Inactivated Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Inactivated Hepatitis A Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Inactivated Hepatitis A Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Inactivated Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Inactivated Hepatitis A Vaccine Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Inactivated Hepatitis A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Inactivated Hepatitis A Vaccine by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Inactivated Hepatitis A Vaccine by Type (2020-2031)
 Figure 52. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Inactivated Hepatitis A Vaccine by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Inactivated Hepatitis A Vaccine by Application (2020-2031)
 Figure 55. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 56. Inactivated Hepatitis A Vaccine Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Hepatitis A Vaccine Market
Global Hepatitis A Vaccination Market Research Report 2025
Mono Hepatitis A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis A and B Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis A and B Vaccine Market Research Report 2025
Global Hepatitis A and B Vaccination Market Research Report 2025
Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Vaccine Market
Hepatitis B Vaccines Market
Global Viral Vector Vaccine for Humans Market Research Report 2024
Hepatitis B Vaccine Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis B Vaccination Market Research Report 2025
Global Hepatitis A immunoglobulin Market Research Report 2025
Global Inactivated Poultry Vaccine Market Research Report 2025
Recombinant Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Killed Vaccines Market Research Report 2025
Mono Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rotavirus Vaccine Market Research Report 2024
Global Hepatitis A Virus HAV Rapid Test Kit Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions